Oxytocin

Pronunciation: ok-see-TOE-sin.

Generic name
oxytocin
Drug class
Synthetic posterior pituitary hormone (oxytocic / uterotonic)
Form
Solution for injection/infusion (commonly 5 IU/mL or 10 IU/mL ampoules), and a 40 IU/mL nasal spray in some markets
Route
Intravenous infusion or intramuscular injection (obstetric use); intranasal spray (lactation-support use, in markets where authorised)
Legal status
Prescription-only, hospital/specialist-administered injectable (Schedule 4 in Australia)

Availability and supply rules vary by country

Trade names by country: United States · United Kingdom · Canada · Australia · New Zealand

Australia: Syntocinon (injection and nasal spray); Oxytocin APX (generic); Syntometrine (combination) (5) · Full directory

What oxytocin is and how it works

Oxytocin is a synthetic version of a natural hormone that causes the uterus to contract. It is given by hospital staff, by IV infusion or injection, to start or strengthen labour for specific medical reasons, and to help the uterus contract after birth to control bleeding (postpartum haemorrhage). (1)

Oxytocin carries genuine, serious risks if given at too high a dose or for too long: overly strong or frequent contractions can injure the uterus or affect the baby, and very high, prolonged doses combined with large amounts of IV fluid can rarely cause a dangerous drop in blood sodium (water intoxication). Because of these real risks, oxytocin is always given and closely monitored by trained hospital staff, at an individually judged rate -- it is not used for starting labour just for convenience (elective induction) without a medical reason.

Mechanism of action: how oxytocin works

Oxytocin is a synthetic nonapeptide identical to the natural posterior pituitary hormone. It binds oxytocin receptors on uterine smooth muscle to stimulate rhythmic contractions, and has a weak, dose-dependent antidiuretic (water-retaining) effect via structural similarity to antidiuretic hormone (vasopressin), which underlies the water-intoxication risk at high, prolonged doses. (1) (2)

What oxytocin is used for

Induction of labour for a medical reason

Used to start labour when there is a specific medical reason to do so -- such as a pregnancy going past term, waters breaking early (premature rupture of membranes), pre-eclampsia, or certain maternal conditions like diabetes or Rh sensitisation -- not for elective/convenience induction without a medical indication. (1) (6)

Augmentation (strengthening) of labour

Used to strengthen contractions in selected cases where labour has started but progress has slowed because contractions are too weak (uterine inertia). (1) (6)

Control of bleeding after childbirth (postpartum haemorrhage)

Given during or after the third stage of labour to help the uterus contract and control postpartum bleeding. (1) (5)

Disorders of lactation (milk ejection) -- specific markets only

An intranasal oxytocin spray is registered in some markets (including Australia) to support milk ejection (let-down) for breastfeeding; this is a separate formulation and indication from the injectable obstetric uses above. (5) (3)

Before taking oxytocin

Do not take / not appropriate for

  • Oxytocin is not given for elective induction of labour -- starting labour purely for convenience when there is no medical reason for induction. (all countries) (1)
  • Oxytocin is not given if there is significant cephalopelvic disproportion (the baby's head is too large for the pelvis) or an unfavourable fetal position such as a transverse lie. (all countries) (1) (2)
  • Oxytocin is not given where vaginal delivery itself is contraindicated -- for example, total placenta praevia/vasa praevia, cord presentation or prolapse, or certain active infections/cancers of the cervix. (all countries) (1) (2)
  • Oxytocin is not given if there is fetal distress without imminent delivery, or a uterine scar from major surgery such as a classical caesarean section. (all countries) (1) (2)

Tell your clinician about

  • Any previous caesarean section or uterine surgery.
  • Whether this is a multiple pregnancy (twins or more), or if you have had many previous pregnancies (grand multiparity) -- these raise uterine rupture risk.
  • Any heart condition, since oxytocin can affect heart rhythm, especially with rapid injection.
  • Any history of very low blood sodium or fluid-balance problems.
(1) (2)

How to take oxytocin

  • Oxytocin is given only in a hospital/monitored setting, by IV infusion (most common for labour induction/augmentation) or by injection, at a rate individually judged and continuously adjusted by your obstetric care team.
  • You will be monitored closely (contractions, fetal heart rate, and your own vital signs) throughout administration because of the genuine risks of overstimulation and, with high prolonged doses, water intoxication.
  • The exact maximum infusion rate used genuinely differs between countries and hospital protocols -- your care team will follow their local protocol and your specific clinical situation, not a single universal number.
(1) (2)

Procedures and treatment changes

Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4) (5) (6)

Missed dose

Not applicable -- oxytocin is administered and continuously adjusted by hospital staff during labour, delivery, or the immediate postpartum period, not self-administered at home on a dosing schedule.

Overdose

Oxytocin overdose/overstimulation is managed immediately by the clinical team (typically by reducing or stopping the infusion and providing supportive care); it is not a situation a patient manages themselves. Seek immediate medical attention for any of the emergency warning signs below. (1)

Side effects

Side effects and their urgency vary; report severe, persistent, or concerning symptoms.

Stronger or more frequent uterine contractions than expected.

What to notice: Stronger or more frequent uterine contractions than expected.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)

Nausea or vomiting.

What to notice: Nausea or vomiting.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (2)

Serious warnings

Signs of uterine overstimulation or rupture — high caution

Symptoms: Contractions that are unusually strong, frequent, or prolonged; severe abdominal pain; vaginal bleeding; signs of fetal distress detected by the care team.

Action: Your obstetric team monitors continuously for this and will immediately reduce or stop the oxytocin infusion in response, since overstimulation can lead to uterine rupture, cervical/vaginal injury, postpartum haemorrhage, or reduced oxygen to the baby. Report any severe or unusual pain to your care team immediately. (1) (2)

Signs of water intoxication (very low blood sodium) — high caution

Symptoms: Severe headache, confusion, drowsiness, seizures, or loss of consciousness -- this is a rare complication linked specifically to large oxytocin doses given over a long period together with large volumes of IV fluid.

Action: This requires immediate medical attention and is treated in hospital with fluid restriction, correction of electrolytes, and control of seizures; maternal death from oxytocin-induced water intoxication has been reported, which is why total dose and infusion duration/fluid volume are carefully limited and monitored by your care team. (1) (2)

Signs of a heart rhythm problem — high caution

Symptoms: Palpitations, chest pain, dizziness, or fainting.

Action: Report to your care team immediately -- oxytocin, especially given as a rapid injection, has been linked to heart rhythm changes (including, per the UK product information, QTc prolongation) and, historically, to abnormal heart rhythms when combined with certain anaesthetics. (2) (1)

Interactions

  • Historically, concomitant use with cyclopropane anaesthesia was associated with abnormal maternal heart rhythms; your anaesthetic and obstetric teams will coordinate care around this. (1)
  • Other medicines that affect heart rhythm may add to oxytocin's own, generally low, cardiovascular risk -- your care team will consider your full medicine list. (2)

Pregnancy, breastfeeding, kidney/liver function, age

Pregnancy

Oxytocin's obstetric uses are specifically for labour induction/augmentation and postpartum care during pregnancy and childbirth, under close hospital supervision, for defined medical indications -- not for elective/convenience induction. (1) (2) (3) (4) (5) (6)

Breastfeeding

The obstetric (injectable) uses are around the time of birth; a separate intranasal oxytocin spray is used in some markets specifically to support breastfeeding/milk ejection. Discuss any use during breastfeeding with your clinician. (1) (2) (3) (4) (5) (6)

Children

Not applicable -- oxytocin's uses reviewed for this dossier are obstetric (labour, delivery, postpartum) and lactation-support uses in adults. (1) (2) (3) (4) (5) (6)

Hepatic_impairment

Not specifically quantified in the sources reviewed for this dossier; use is hospital-supervised regardless. (1) (2) (3) (4) (5) (6)

Renal_impairment

Not specifically quantified in the sources reviewed for this dossier; fluid and electrolyte status is monitored closely regardless, given the water-intoxication risk. (1) (2) (3) (4) (5) (6)

Monitoring

Before starting

  • Confirmation of a genuine medical indication for induction/augmentation (not elective induction)
  • Fetal position and pelvic assessment
  • Baseline maternal vital signs and fluid/electrolyte status

During treatment

  • Continuous or frequent monitoring of uterine contractions (frequency, strength, duration) and fetal heart rate throughout the infusion.
  • Careful tracking of total oxytocin dose, infusion duration, and IV fluid volume given, specifically to reduce water-intoxication risk.
  • Maternal heart rate/rhythm and blood pressure monitoring, particularly around rapid administration or bolus doses.
(1) (2)

Storage

Oxytocin injection/infusion is stored and prepared by hospital pharmacy/nursing staff according to the product label, typically refrigerated or at controlled room temperature depending on the product; not applicable for patient home storage in its obstetric use.

Professional information

Clinician-facing context only, sourced from the current US FDA Pitocin prescribing information and UK SmPC, plus Canada/Australia/New Zealand regulator sources reviewed for this dossier; verify against the current full label/local protocol before administering.

United States

Indication: Labour induction/augmentation (medically indicated only); postpartum haemorrhage control

Dose summary: IV titration starting 0.5-1 mU/min, incremental to rarely-required rates above 9-10 mU/min; PPH 10-40 units IV infusion or 10 units IM.

Renal context: No specific adjustment described in sources reviewed; fluid/electrolyte status monitored regardless. (1)

United Kingdom

Indication: Labour induction/augmentation (medically indicated only)

Dose summary: Standard maximum infusion rate 40 drops/minute (20 mU/minute) for term pregnancies; higher rates require specific clinical justification.

Renal context: No specific adjustment described in sources reviewed. (2)

Mechanism of action

Hepatic guidance

Not specifically quantified in the sources reviewed for this dossier.

Overdose note

Managed by immediately reducing/stopping the infusion and providing supportive care (fluid restriction, electrolyte correction, seizure control) for water intoxication; continuous fetal/maternal monitoring guides management of uterine overstimulation. (1) (2)

Frequently asked questions

Does oxytocin (Pitocin) have a boxed warning?

No -- the current US FDA label for Pitocin does not carry a boxed warning. It does carry serious, genuine Warnings and Precautions covering uterine overstimulation/rupture risk, water intoxication with large prolonged doses, and cardiovascular effects, which your care team manages through careful dosing and continuous monitoring. (1)

Can oxytocin be used just to schedule my delivery for convenience?

No. Oxytocin/Pitocin is specifically not indicated for elective induction of labour -- that is, starting labour when there is no medical reason for induction. It is used to induce or augment labour only for defined medical indications, such as a pregnancy going past term, premature rupture of membranes, or pre-eclampsia. (1)

What is water intoxication and why does it matter with oxytocin?

Water intoxication is a rare but serious complication where the body retains too much water relative to sodium, which can cause seizures, coma, and has rarely been fatal. It has been linked specifically to large oxytocin doses (40-50 milliunits/minute) given over long periods together with large volumes of IV fluid -- which is why your care team carefully limits and monitors both the oxytocin dose and the fluids given alongside it. (1) (2)

What is the mechanism of action of oxytocin?

Oxytocin is a synthetic nonapeptide identical to the natural posterior pituitary hormone. It binds oxytocin receptors on uterine smooth muscle to stimulate rhythmic contractions, and has a weak, dose-dependent antidiuretic (water-retaining) effect via structural similarity to antidiuretic hormone (vasopressin), which underlies the water-intoxication risk at high, prolonged doses. (1) (2)

What is the generic name of Oxytocin?

The generic name is oxytocin. (1) (5)

What class of drug is oxytocin?

Oxytocin is classed as: Synthetic posterior pituitary hormone (oxytocic / uterotonic). (1) (5)

References

  1. PITOCIN (oxytocin) injection -- full prescribing informationU.S. Food and Drug Administration / DailyMed (NIH), full prescribing information · United States · accessed 2026-07-30 · source 1
  2. Oxytocin 10 IU/ml Solution for infusion -- Summary of Product Characteristicselectronic medicines compendium (emc), United Kingdom · United Kingdom · accessed 2026-07-30 · source 2
  3. Oxytocin -- list of nationally authorised medicinal products (PSUSA/00002263/202006, EMA/78560/2021)European Medicines Agency (EMA) -- Periodic Safety Update Report Single Assessment (PSUSA) list of nationally authorised medicinal products · European Union · accessed 2026-07-30 · source 3
  4. Oxytocin Injection USP / Syntocinon -- Health Canada Drug Product Database listingHealth Canada Drug Product Database (DPD) · Canada · accessed 2026-07-30 · source 4
  5. SYNTOCINON (oxytocin) injection and nasal spray -- ARTG entries (13383, 13395, 13382, 425470, 425471); OXYTOCIN APX generic (225656); SYNTOMETRINE combination (13396)Therapeutic Goods Administration (TGA), Australia · Australia · accessed 2026-07-30 · source 5
  6. Syntocinon / Oxytocin-Apotex / Oxytocin-BNM -- New Zealand Data Sheets (multiple registered brands)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · New Zealand · accessed 2026-07-30 · source 6

Brand names by country

Single-ingredient oxytocin names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.

Priority countries

United States

  • Pitocin10 [iU]/mL · par health usa, llc

United Kingdom

  • Syntocinon / Oxytocin (generic) (2)MHRA licensed emc smpc confirmed · 10 IU/mL · multiple UK manufacturers

Canada

  • Oxytocin Injection USP (Pfizer Canada); Syntocinon Injection (4)Health Canada DPD listed market authorisation confirmed · 10 IU/mL · Pfizer Canada and other suppliers

Australia

  • Syntocinon (injection and nasal spray); Oxytocin APX (generic); Syntometrine (combination) (5)TGA ARTG registered 1991-08-21 confirmed · 5 IU/mL, 10 IU/mL injection, 40 IU/mL nasal spray · Arrotex Pharmaceuticals Pty Ltd and other suppliers

New Zealand

  • Syntocinon, Oxytocin-Apotex, Oxytocin-BNM, Syntometrine (combination) (6)Medsafe datasheets confirmed multiple brands · varies by brand · multiple NZ-registered suppliers
View brands in additional countries.

European Union

Syntocinon (generic; nationally authorised per member state) (3)